This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Darland, G. Articles by Birnbaum, J. Search for Related Content PubMed PubMed Citation Articles by Darland, G. Articles by Birnbaum, J.

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1977 April; 11(4): 725-734
Copyright © 1977 American Society for Microbiology. All Rights Reserved.

Cefoxitin Resistance to Beta-Lactamase: a Major Factor for Susceptibility of Bacteroides fragilis to the Antibiotic

Merck Institute for Therapeutic Research, Rahway, New Jersey 07065

ABSTRACT

Toluene-treated cell suspensions of Bacteroides fragilis were used to screen clinical isolates for the production of ß-lactamase. Approximately one-third of the isolates possessed considerable cephalosporinase activity. A significant correlation was found between ß-lactamase production and resistance to cephalosporin antibiotics. Several isolates were resistant to cefuroxime and cefamandole and produced enzymes capable of hydrolyzing these antibiotics. However, none of the 79 strains tested could hydrolyze the cephamycin derivative, cefoxitin. A large percentage (>90%) of the strains were susceptible to cefoxitin. Therefore, resistance to lactamase hydrolysis is a major factor for the effectiveness of cefoxitin against B. fragilis. Detailed studies of four isolates suggest that two different enzymes may be produced. Both are cephalosporinases but differ with regard to cellular distribution and substrate specificity. Cefoxitin is not a substrate for either enzyme, but it is an excellent competitive inhibitor (K_i 0.1 µM).